Aldactone

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Spironolactone 100mg

Disponible depuis:

Pfizer New Zealand Limited

DCI (Dénomination commune internationale):

Spironolactone 100 mg

Dosage:

100 mg

forme pharmaceutique:

Film coated tablet

Composition:

Active: Spironolactone 100mg Excipient: Calcium sulfate dihydrate Peppermint 961149/701213 Hypromellose Macrogol 400 Magnesium stearate Maize starch Opaspray yellow M-1-6032B Povidone

Unités en paquet:

Blister pack, 100 tablets

classe:

Prescription

Type d'ordonnance:

Prescription

Fabriqué par:

Piramal Healthcare UK Limited

indications thérapeutiques:

Essential hypertension; oedematous conditions including congestive cardiac failure, cirrhosis of the liver, (with or without ascites) and the nephrotic syndrome; diagnosis and treatment of primary aldosteronism, as adjunctive therapy in malignant hypertension; in diuretic induced hypokalaemia/hypomagnesaemia when other measures are considered inappropriate or inadequate; prophylaxis of hypokalaemia in patients taking digitalis when other measures are considered inadequate or inappropriate, hirsutism.

Descriptif du produit:

Package - Contents - Shelf Life: Blister pack, - 100 tablets - 60 months from date of manufacture stored at or below 30°C - Bottle, plastic, - 100 tablets - 60 months from date of manufacture stored at or below 30°C

Date de l'autorisation:

1969-12-31